Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vertex Pharmaceuticals
Biotech
Vertex, beaten by AATD again, drops 2 assets on discard pile
Vertex axed two more drug candidates in response to underwhelming data but plans to use the missteps to inform the next wave of preclinical prospects.
Nick Paul Taylor
Aug 2, 2024 5:39am
Vertex mines for more gene editing riches with $15M Orum deal
Jul 16, 2024 7:00am
Vertex files FDA ask for next-gen cystic fibrosis candidate
May 7, 2024 7:30am
As pharma eyes shiny obesity drugs, Vertex tops orphan drug list
Apr 24, 2024 12:01am
How Vertex became the VIP of Alpine's exclusive data room
Apr 23, 2024 11:19am
Vertex inches closer to acute pain market as FDA accepts VX-548
Apr 18, 2024 10:50am
